IceCure Medical/$ICCM
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About IceCure Medical
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
Ticker
$ICCM
Sector
Primary listing
Industry
Health Care Equipment & Supplies
Headquarters
Caesarea, Israel
Employees
65
ISIN
IL0011224156
Website
IceCure Medical Metrics
BasicAdvanced
$56M
-
-$0.29
2.59
-
Price and volume
Market cap
$56M
Beta
2.59
52-week high
$1.66
52-week low
$0.48
Average daily volume
230K
Financial strength
Current ratio
1.89
Quick ratio
1.269
Long term debt to equity
1.8
Total debt to equity
6.333
Profitability
EBITDA (TTM)
-15.367
Gross margin (TTM)
42.77%
Net profit margin (TTM)
-467.37%
Operating margin (TTM)
-479.77%
Revenue per employee (TTM)
$50,000
Management effectiveness
Return on assets (TTM)
-72.28%
Return on equity (TTM)
-173.47%
Valuation
Price to revenue (TTM)
15.558
Price to book
9.28
Price to tangible book (TTM)
9.28
Price to free cash flow (TTM)
-3.69
Free cash flow yield (TTM)
-27.10%
Free cash flow per share (TTM)
-25.74%
Growth
Revenue change (TTM)
0.34%
Earnings per share change (TTM)
-9.59%
3-year revenue growth (CAGR)
-1.73%
10-year revenue growth (CAGR)
9.85%
3-year earnings per share growth (CAGR)
-10.52%
10-year earnings per share growth (CAGR)
-22.78%
What the Analysts think about IceCure Medical
Analyst ratings (Buy, Hold, Sell) for IceCure Medical stock.
IceCure Medical Financial Performance
Revenues and expenses
IceCure Medical Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for IceCure Medical stock?
IceCure Medical (ICCM) has a market cap of $56M as of June 20, 2025.
What is the P/E ratio for IceCure Medical stock?
The price to earnings (P/E) ratio for IceCure Medical (ICCM) stock is 0 as of June 20, 2025.
Does IceCure Medical stock pay dividends?
No, IceCure Medical (ICCM) stock does not pay dividends to its shareholders as of June 20, 2025.
When is the next IceCure Medical dividend payment date?
IceCure Medical (ICCM) stock does not pay dividends to its shareholders.
What is the beta indicator for IceCure Medical?
IceCure Medical (ICCM) has a beta rating of 2.59. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.